Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 1 7 12 147
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 1 10 58
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 0 0 9 129
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 1 2 3 156 1 8 34 424
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 1 5 19 694
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 1 44 0 5 21 180
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 1 2 24 2 10 28 75
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 1 1 17 1 6 25 54
Optimizing Tax Administration Policies with Machine Learning 0 0 2 267 0 2 29 718
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 0 4 12 209
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 1 3 5 29 3 7 29 95
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 0 5 25 155
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 0 89 0 5 22 150
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 1 4 13 103
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 0 1 15 135
What exactly is public in a public good game? A lab-in-the-field experiment 0 2 3 159 0 5 19 382
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 0 95 2 8 29 182
Total Working Papers 2 9 17 1,478 12 83 351 3,890


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An experimental manipulation of divisibility in the public good game 0 1 1 1 1 4 7 7
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 0 17 0 4 12 99
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 0 2 15 49
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 0 3 16 31
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 0 4 26
Machine learning and the optimization of prediction-based policies 1 1 2 7 2 6 25 40
R&D and market size: Who benefits from orphan drug legislation? 0 1 1 5 0 8 19 49
R&D investments, financing constraints, exporting and productivity 0 0 2 59 0 3 20 186
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 0 1 2 2 1 6 13 13
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 1 20 1 7 18 131
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 0 1 7 14
The impact of managed entry agreements on pharmaceutical prices 0 0 1 16 0 3 19 98
The impact of social pressure on tax compliance: A field experiment 0 0 2 28 0 5 12 139
When the two ends meet: an experiment on cooperation and social capital 0 0 2 7 0 3 24 51
Total Journal Articles 1 4 14 177 5 55 211 933


Statistics updated 2026-07-10